Wilson; Wyndham

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilson; Wyndham.The latest application filed is for "methods for identifying, diagnosing, and predicting survival of lymphomas".

Company Profile

1.7.7

Wilson; Wyndham - Washington DC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for identifying, diagnosing, and predicting survival of lymphomas Grant 10,697,975 - Staudt , et al.	2020-06-30
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas App 20180011106 - Staudt; Louis M. ; et al.	2018-01-11
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) Grant 8,748,114 - Staudt , et al. June 10, 2	2014-06-10
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas App 20120225793 - Staudt; Louis M. ; et al.	2012-09-06
Methods for identifying, diagnosing, and predicting survival of lymphomas Grant 8,131,475 - Staudt , et al. March 6, 2	2012-03-06
Zap-70 Expression As A Marker For Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (cll/sll) App 20110236915 - Staudt; Louis M. ; et al.	2011-09-29
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) Grant 7,981,610 - Staudt , et al. July 19, 2	2011-07-19
Taxol treatment of cancer Grant RE40,839 - Wilson , et al. July 7, 2	2009-07-07
Zap-70 Expression As A Marker For Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (cll/sll) App 20080227741 - Staudt; Louis M. ; et al.	2008-09-18
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) Grant 7,329,502 - Staudt , et al. February 12, 2	2008-02-12
Methods for identifying, diagnosing, and predicting survival of lymphomas App 20070105136 - Staudt; Louis M. ; et al.	2007-05-10
Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma App 20050244828 - Kreitman, Robert J. ; et al.	2005-11-03
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) App 20030203416 - Staudt, Louis M. ; et al.	2003-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.